Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives.
Anti-Infective Agents
/ pharmacology
Antineoplastic Agents
/ pharmacology
Antioxidants
/ pharmacology
Bacteria
/ drug effects
Biphenyl Compounds
/ chemistry
Cell Line, Tumor
Chalcones
/ chemical synthesis
Fungi
/ drug effects
Humans
Isoxazoles
/ chemical synthesis
Microbial Sensitivity Tests
Picrates
/ chemistry
Pyrazoles
/ chemical synthesis
antibacterial activity
anticancer activity
antifungal activity
chalcones
dihydropyrazole
isoxazole
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
26 Feb 2020
26 Feb 2020
Historique:
received:
25
01
2020
revised:
17
02
2020
accepted:
23
02
2020
entrez:
1
3
2020
pubmed:
1
3
2020
medline:
15
12
2020
Statut:
epublish
Résumé
Our previous work identified isoxazole-based chalcones and their dihydropyrazole derivatives as two important five-membered heterocycles having antitubercular activity. Hence, in the present study, we biologically evaluated 30 compounds, including 15 isoxazole ring-containing chalcones (
Identifiants
pubmed: 32110945
pii: molecules25051047
doi: 10.3390/molecules25051047
pmc: PMC7179112
pii:
doi:
Substances chimiques
Anti-Infective Agents
0
Antineoplastic Agents
0
Antioxidants
0
Biphenyl Compounds
0
Chalcones
0
Isoxazoles
0
Picrates
0
Pyrazoles
0
1,1-diphenyl-2-picrylhydrazyl
DFD3H4VGDH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Med Chem. 2012 Jan 26;55(2):812-23
pubmed: 22148173
BMC Chem. 2019 Apr 1;13(1):48
pubmed: 31384796
Acta Pharm Sin B. 2019 Mar;9(2):335-350
pubmed: 30972281
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1352-1361
pubmed: 30251900
Eur J Med Chem. 2015 Jan 7;89:304-9
pubmed: 25462246
Eur J Med Chem. 2017 May 5;131:237-254
pubmed: 28329730
Molecules. 2010 Aug 04;15(8):5336-53
pubmed: 20714300
Eur J Med Chem. 2001 Jun;36(6):539-43
pubmed: 11525844
Bioorg Med Chem Lett. 2005 Nov 15;15(22):5030-4
pubmed: 16168645
Arch Pharm Res. 2012 May;35(5):807-21
pubmed: 22644849
Curr Top Med Chem. 2019;19(9):662-682
pubmed: 30834836
Molecules. 2013 Feb 28;18(3):2683-711
pubmed: 23449067
Recent Pat Anticancer Drug Discov. 2015;10(1):97-115
pubmed: 25138130
Molecules. 2016 Aug 03;21(8):
pubmed: 27527130
Eur J Med Chem. 2013 Sep;67:252-62
pubmed: 23871905
Farmaco. 1996 Jan;51(1):59-63
pubmed: 8721763
Curr Top Med Chem. 2017 Nov 20;17(28):3146-3169
pubmed: 28914193
J Med Chem. 2017 Aug 24;60(16):7108-7122
pubmed: 28749666
Arch Pharm (Weinheim). 2011 Aug;344(8):514-22
pubmed: 21681810
Future Med Chem. 2012 Dec;4(18):2311-23
pubmed: 23234553
Molecules. 2017 Nov 30;22(12):
pubmed: 29189730
Bioorg Med Chem Lett. 2013 Dec 1;23(23):6269-73
pubmed: 24139584
J Med Chem. 2011 Oct 27;54(20):7280-8
pubmed: 21905669
Chem Commun (Camb). 2016 Aug 9;52(66):10190-2
pubmed: 27469938
Med Chem. 2018;14(4):333-343
pubmed: 29065840
Front Pharmacol. 2019 Nov 15;10:1341
pubmed: 31803052
Bioorg Med Chem. 2014 Nov 1;22(21):5804-12
pubmed: 25311566
Bioorg Med Chem. 2002 Aug;10(8):2795-802
pubmed: 12057669
Braz Dent J. 2012;23(1):22-7
pubmed: 22460310
Infect Disord Drug Targets. 2019;19(3):310-321
pubmed: 30556506
Open Med Chem J. 2017 Sep 26;11:92-108
pubmed: 29151986
J Enzyme Inhib Med Chem. 2014 Jun;29(3):427-42
pubmed: 23808806
Eur J Med Chem. 2018 Jan 1;143:891-898
pubmed: 29227929
Eur J Med Chem. 2014 Feb 12;73:187-94
pubmed: 24398288
Int J Med Chem. 2017;2017:6873924
pubmed: 29441207
Chem Rev. 2017 Jun 28;117(12):7762-7810
pubmed: 28488435
Anticancer Agents Med Chem. 2015;15(1):131-6
pubmed: 25142319
Drug Res (Stuttg). 2013 Jan;63(1):46-51
pubmed: 23447048
Med Chem. 2016;12(2):184-90
pubmed: 26362768